Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
PCVX
#848
Vaxcyte, Inc. Common Stock
61.740
0
+3.31%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+3.31%
Variazione Mensile
+13.62%
Variazione di 6 mesi
+45.96%
Variazione Annuale
+45.96%
Chiusura Precedente
59.760
0
Open
61.740
0
Bid
Ask
Low
61.740
0
High
61.740
0
Volume
145
Mercati
Mercato Azionario Statunitense
Salute
PCVX
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
124.64 M
128.76 M
129 M
129.82 M
130.91 M
143.92 M
—
Valuation ratios
Enterprise value
13.19 B
10.15 B
4.52 B
3.91 B
4.43 B
6.47 B
19.34 B
Price to earnings ratio
-24.79
-21.54
-9.46
-7.91
-7.44
-8.2
-33.01
Price to sales ratio
1 113.08
—
—
—
—
—
—
Price to cash flow ratio
26.72
22.06
10.3
9.24
8.83
9.58
37.94
Price to book ratio
1.52
3.02
0.4
0.32
0.38
2.34
3.44
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.03
0.04
0.04
0.05
0.07
0.08
0.24
Return on equity %
0.03
0.04
0.04
0.05
0.07
0.09
0.26
Return on invested capital %
53.9
—
41.35
53.35
60.38
72.9
227.97
Gross margin %
100
—
—
—
—
—
—
Operating margin %
1 655.91
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
1 220.4
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
17.88
12.75
17.7
11.11
8.83
7.91
45.55
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.49
0.91
1.23
0.89
1.05
1.65
4.82
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
17.63
14.32
12.32
12.21
12.57
11.47
48.57
Net current asset value per share
17.9
14.66
12.65
12.61
12.98
11.96
50.2
Tangible book value per share
27.63
27.1
23.58
22.58
21.24
19.73
87.13
Working capital per share
16.9
13.51
11.94
11.48
11.51
10.45
45.37
Book value per share
27.63
27.1
23.58
22.58
21.24
19.73
87.13
Notizie
BTIG alza il target su Vaxcyte a 89$ per il vantaggio nella copertura
BTIG raises Vaxcyte price target to $89 on vaccine breadth edge
Leerink alza il target su Vaxcyte per l’espansione della pipeline vaccinale
Leerink raises Vaxcyte stock price target on vaccine pipeline expansion
Vaxcyte, Inc. (PCVX) Q4 2025 Earnings Call Transcript
Tutti gli occhi sui risultati di Vaxcyte con vaccino pneumococcico vicino a dati chiave
Ovintiv to Report Q4 Earnings: What's in Store for the Stock?
Vaxcyte closes $632.5 million public offering of common stock
Vaxcyte fissa il prezzo dell’offerta pubblica di azioni ordinarie a 550 milioni di dollari
Vaxcyte prices $550 million public offering of common stock
Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance
Vaxcyte launches $500 million public offering of common stock